Estimating prognosis of patients with liver disease based on blood parameters
Phase 3
- Conditions
- Health Condition 1: K740- Hepatic fibrosis
- Registration Number
- CTRI/2021/09/036283
- Lead Sponsor
- SELFDR ISHITA GUPTA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All patients aged >= 18 years admitted at Kasturba
Hospital with the confirmed diagnosis of liver cirrhosis of any underlying etiology will be included in the study.
Exclusion Criteria
Patients aged <18 years
Co-existence of hepatocellular carcinoma or other malignant tumour
Patients with haematological malignancy and autoimmune disease
Patients with acquired immunodeficiency syndrome
Patients presenting with any kind of infections such as tuberculosis will also excluded from the study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ymphocte monocyte ratio as an independent, cost effective tools to predict severity of disease in liver cirrhosis patients.Timepoint: 1 YEAR
- Secondary Outcome Measures
Name Time Method MR as an independent indicator in inflammatory diseasesTimepoint: 1 YEAR